NASDAQ · Financial Statements
Adverum Biotechnologies, Inc. (ADVM) Financial Statements
$4.36
NASDAQ: ADVM
Market Cap $96.26M
Overview Financials Dividend Adverum Biotechnologies, Inc. most recently reported annual revenue of $1.0M, net profit of $-131.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $0 $8.0M $0 $4.0M $1.0M Operating Profit $-118.0M $-146.0M $-157.0M $-129.0M $-139.0M Net Profit $-118.0M $-146.0M $-155.0M $-122.0M $-131.0M EPS $-1.26 $-1.48 $-2.67 $-2.02 $-6.62 Op Margin — -1948.3% — -3581.7% -13915.9%
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $483.0M $440.0M $308.0M $156.0M $180.0M Total Liabilities $48.0M $124.0M $127.0M $89.0M $109.0M Cash $62.0M $34.0M $68.0M $75.0M $61.0M Borrowings $31.0M $103.0M $107.0M $74.0M $92.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-79.0M $-108.0M $-108.0M $-91.0M $-92.0M Investing Cash Flow $-292.0M $64.0M $130.0M $96.0M $-42.0M Financing Cash Flow $12.0M $1.0M $0 $0 $1.0M Net Cash Flow $-3.0M $-27.0M $34.0M $6.0M $-14.0M Free Cash Flow $-91.0M $-123.0M $-120.0M $-92.0M $-93.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.01 EV / EBITDA -1.12 FCF Yield -114.42% Quick Ratio 0.65 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock